Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity: A Single Center, Double-Blind, Placebo-controlled, Flexible-Dose Study in Outpatients is a PHASE3 clinical asset sponsored by Lindner Center of HOPE in Binge Eating Disorder Associated With Obesity. SEO and diligence focus: Zonegran, sugar pill, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.